CTL-mediated APC elimination: Constraining effective humoral immunity
Journal of Cellular and Molecular Immunology · 2025
DOI: 10.46439/immunol.4.039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Immunology, 2025. Verfasst von Yongxin Zhang und 1 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Cytotoxic CD8+ T lymphocytes (CTLs) are classically viewed as effectors of cellular immunity, eliminating infected or malignant cells. Yet an underappreciated facet of their biology is their capacity to impose negative regulation on antigen-presenting cells (APCs), including dendritic cells (DCs), macrophages, and B cells. In this review, we explore the hypothesis that overly robust CTL responses may inadvertently impair humoral immunity by prematurely trimming APC lifespan, constraining T follicular helper (Tfh) induction, and reducing antibody production and immune durability. We review evidence for CTL-mediated APC killing, mechanistic modulators, and cross-talk with helper T cells, then connect this to Tfh–B cell dynamics, immune complex formation on follicular dendritic cells (FDCs), and long-term antibody retention. We also discuss how this process fits into broader immune regulation, its clinical implications for autoimmune diseases, cancer, and infections (including limited human studies), and propose experimental strategies to validate or disprove this regulatory axis. Finally, we outline implications for vaccine design.
Zitieren
APA
Zhang, Y., & Yu, Y. (2025). CTL-mediated APC elimination: Constraining effective humoral immunity. Journal of Cellular and Molecular Immunology. https://doi.org/10.46439/immunol.4.039
Vancouver
Zhang Y, Yu Y. CTL-mediated APC elimination: Constraining effective humoral immunity. Journal of Cellular and Molecular Immunology. 2025. doi:10.46439/immunol.4.039
BibTeX
@article{Zhang2025,
author = {Zhang, Yongxin and Yu, Yanyan},
title = {CTL-mediated APC elimination: Constraining effective humoral immunity},
journal = {Journal of Cellular and Molecular Immunology},
year = {2025},
doi = {10.46439/immunol.4.039}
}
EUVIMED